Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Liver Disease”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05749822
What this trial is testing

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases 104
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Large-scale testing (Phase 3)Study completedNCT00048724
What this trial is testing

Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)

Who this might be right for
Chronic Hepatitis CCirrhosis
Merck Sharp & Dohme LLC 631
Post-approval studies (Phase 4)Study completedNCT00441974
What this trial is testing

Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 1,470
Not applicableUnknownNCT02653846
What this trial is testing

Correlation of Liver and Spleen Stiffness by RT-2D-SWE and Severity of Portal Hypertension by HVPG

Who this might be right for
Chronic Liver Diseases
University Hospital Dubrava 50
Testing effectiveness (Phase 2)Study completedNCT01483742
What this trial is testing

Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 43
Not applicableActive Not RecruitingNCT06888310
What this trial is testing

Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease

Who this might be right for
NASHNAFLD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 408
Large-scale testing (Phase 3)Study completedNCT02707952
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 295
Not applicableUnknownNCT04421118
What this trial is testing

The Precise Selection of Stent Diameter for Portal Hypertension Patients With TIPS

Who this might be right for
Compensated Advanced Chronic Liver DiseasePortal Hypertension
First Affiliated Hospital of Zhejiang University 60
Not applicableNot Yet RecruitingNCT07082751
What this trial is testing

Prognostic Model for MASLD Related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseCompensated Cirrhosis
Beijing Friendship Hospital 228
Large-scale testing (Phase 3)Study completedNCT00805675
What this trial is testing

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Who this might be right for
Hepatitis B Virus
Novartis Pharmaceuticals 83
Post-approval studies (Phase 4)Study completedNCT00529178
What this trial is testing

Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease

Who this might be right for
Hypercholesterolemia
Bristol-Myers Squibb 232
Not applicableUnknownNCT05357599
What this trial is testing

The Use of Endoscopic Ultrasound-Guided Portal Pressure Measurements to Guide Beta-Blocker Therapy in Patients With Compensated Cirrhosis

Who this might be right for
CirrhosisCompensated CirrhosisPortal Hypertension
University of Southern California 30
Post-approval studies (Phase 4)UnknownNCT04997564
What this trial is testing

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
Peking University First Hospital 120
Not applicableStudy completedNCT03071133
What this trial is testing

Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 344
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT02167945
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 615
Large-scale testing (Phase 3)Study completedNCT00115245
What this trial is testing

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Not applicableEnded earlyNCT03658551
What this trial is testing

Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy

Who this might be right for
Cirrhosis, Liver
Johannes Gutenberg University Mainz 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation